Skip to content


September 24, 2018 – In advance of the first-ever United Nations High-Level Meeting on Tuberculosis (TB), a new brief from Treatment Action Group (TAG) — Funding for TB Research: Recent Momentum Must Inspire Bold Commitments — shows that global funding for TB research and development (R&D) reached a new high of USD $767.8 million in 2017. This marks the second year in a row that funding for TB research exceeded $700 million. This positive trend should encourage heads of state and government convening in New York for the UN High-Level Meeting to commit to reaching even more ambitious financial targets moving forward.

The findings summarized in the brief released today represent preliminary results from an annual global survey of TB research funders conducted by TAG with support from the Stop TB Partnership. The survey, now in its 13th year, is the longest running and most comprehensive record of public, philanthropic, private, and multilateral institutions’ contributions to TB research each year.

Final numbers and accompanying analyses will be available in the forthcoming report TB Research Funding Trends, 2005–2017 in December 2018.

Back To Top